KCG
FLNA

Knight Capital Group’s Filana Therapeutics FLNA Stock Holding History

Knight Capital Group’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$57K Buy
+3,693
New +$78.1K ﹤0.01% 3042

Other funds holding FLNA

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
JRJ
Jeffrey R. Jay $127M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MSP
Madison Street Partners Denver, Colorado $3.05M AUM 5.94% 1-Year Est. Return

Knight Capital Group's FLNA Position: Q2 2013 in Review

Knight Capital Group opened a new position in Filana Therapeutics (FLNA) in Q2 2013: 3,693 shares worth $57K. The stake represents ﹤0.01% of the portfolio and ranks #3042 among its holdings.

69 funds tracked by Wall St. Rank hold FLNA as of Q2 2013.

  • Knight Capital Group held 3,693 shares of Filana Therapeutics worth $57K as of Q2 2013.
  • Filana Therapeutics was a new Knight Capital Group position in Q2 2013.
  • Filana Therapeutics made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #3042 holding.
  • 69 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.